SFX by Ex Libris Inc.

Title:	Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A)
Source:	Cell death and Differentiation [1350-9047] Kostylina, G yr:2007

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Bays, Harold E E. "The 'forgotten' bile Acid sequestrants: is now a good time to remember?" American journal of therapeutics 14.6 (2007): 567-80.
description	2.	Staels, B. "Bile acid sequestrants and the treatment of type 2 diabetes mellitus." Drugs 67.10 (2007): 1383-1392.
description	3.	Bays, H. "Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors." Vascular Health and Risk Management 3.5 (2007): 733-42.
description	4.	Insull, W. "Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review." Southern medical journal 99.3 (2006): 257-73.
description	5.	Duriez, P. "CETP inhibition." Lancet, The 370.9603 (2008): 1882-3.
description	6.	Cipollone. "Suppression of the functionally coupled cyclooxygenase-2 /prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans (Circulation (2003) 107, (1479-1785) DOI: 10.1161/01.CIR.0000056530.03783.81)." Circulation 116.17 (2007).
description	7.	Robinson, Dean M M. "Colesevelam: a review of its use in hypercholesterolemia." American journal of cardiovascular drugs 7.6 (2007): 453-65.
description	8.	ACR Subcommittee on RA Guidelines, C. "Guidelines for the management of rheumatoid arthritis: 2002 Update." Arthritis and rheumatism 46.2 (2002): 328-346.
description	9.	Kashyap, Moti L L. "Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia." The American journal of cardiology 89.6 (2002): 672-678.
description	10.	Moore, John D D. "Successful Treatment with Colesevelam HCl and Pravastatin in a Patient Previously Hospitalised with Severe Normal CPK Myopathy on Introduction of Simvastatin." Clinical drug investigation (2005): 417-20.
description	11.	Bays, Harold E E. "Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia." The American journal of cardiology 97.8 (2006): 1198-205.
description	12.	Petrella, R. "Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management." Clinical therapeutics 33.9 (2011): 1190-1203.
description	13.	RIFKIND, BM. "The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease." JAMA 251.3 (1983): 351-64.
description	14.	Lazaridis, K N N. "Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'." Journal of hepatology 35.1 (2001): 134-46.
description	15.	Baxter, John D D. "Metabolism: bile acids heat things up." Nature 439.7075 (2005): 402-403.
description	16.	OF, ANEE. "CONTRIBUTED POSTER PRESENTATIONS." Value in health 10.3 (2005): 258-188.
description	17.	Garbutt, Barbara C. "Baclofen for alcoholism." Lancet, The 370.9603 (2008): 1884-5.
description	18.	Opar, A. "Where now for new drugs for atherosclerosis?" Nature reviews. Drug discovery 6.5 (2007): 334-5.
description	19.	Athyros, Asterios G. "Statins and Regression of Coronary Atherosclerosis." JAMA 297.20 (2007): 2197-.
description	20.	Naruszewicz, M. "Plant sterols beyond low-density lipoprotein-cholesterol." The British journal of nutrition 98.3 (2007): 454-5.